TrialThe oncologist2011
A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.
Ivy Altomare et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled ittrialcites it